Childhood anxiety has quietly become one of the defining health challenges of our time, and the world’s clinics cannot keep up with the demand for care. Now researchers in Portugal have reported a result that could reshape how psychological treatment reaches anxious children: a blended, transdiagnostic program that welds face-to-face group sessions to online components has held its own against Coping Cat, the gold-standard cognitive-behavioral group treatment that has anchored the field for three decades. In the pilot randomized controlled equivalence trial, published on 27 August 2026 in Child Psychiatry & Human Development, a team led by Helena Moreira of the University of Coimbra enrolled 77 children aged 6 to 13 with a primary anxiety disorder and randomly assigned them to either the new program — dubbed Emotion Detectives In–Out — or to the established Coping Cat intervention. By the end of treatment, both groups had improved significantly across most outcomes, with no significant between-group differences on clinician-rated severity or improvement, and on several child-reported measures the digital hybrid actually pulled ahead.

The stakes are considerable. Meta-analytic estimates suggest that roughly one in seven children and adolescents worldwide meets criteria for a psychiatric disorder, and anxiety disorders rank among the most common, most persistent, and most impairing of them. National trend data from the United States show that children’s anxiety and depression rose steadily between 2016 and 2020, while systematic reviews in Europe describe service systems straining under demand that far exceeds capacity. Untreated anxiety casts a long shadow: a United Kingdom birth-cohort study found that anxiety and depression across childhood and adolescence forecast adverse outcomes in young adulthood, and meta-analytic work links pediatric anxiety disorders to broad impairment in quality of life. Anxiety also rarely travels alone — it overlaps heavily with depression, which is precisely why a treatment capable of addressing both holds such appeal. Effective tools exist, and cognitive-behavioral therapy is among the most thoroughly validated interventions in mental health, but the bottleneck is delivery rather than knowledge: too few trained clinicians, long waiting lists, and families for whom weekly clinic visits are logistically or financially out of reach, with studies of help-seeking showing that stigma and uncertainty stop many families from reaching services at all.

The new study rides a broader shift in clinical science: the transdiagnostic movement. Traditional protocols were engineered for specific diagnostic categories, and Coping Cat, developed by Philip Kendall and refined through decades of randomized trials and meta-analyses, has long served as the benchmark against which new childhood anxiety treatments are measured. But anxiety and depression share an underlying machinery: elevated negative affectivity, aversive reactions to one’s own emotions, and a pervasive pattern of avoidance that maintains suffering across diagnostic boundaries. The Unified Protocol, originally developed by David Barlow and colleagues, targets those shared mechanisms directly, teaching patients to notice, tolerate, and approach intense emotions rather than escape them. Its children’s version packages those modules in a playful “Emotion Detectives” format, in which young patients investigate their feelings, map the links among thoughts, body sensations, and behavior, and rehearse brave approach behaviors toward feared situations. Trials in the United States, Japan, Iran, and Portugal have reported encouraging results, and recent meta-analytic work suggests that transdiagnostic programs achieve outcomes comparable to disorder-specific treatments across age groups.

What distinguishes Emotion Detectives In–Out is its delivery architecture. Blended care — the deliberate integration of in-person sessions with internet-based components — has attracted growing interest because systematic reviews suggest it can preserve treatment quality while reducing clinician burden. In the Portuguese program, children attend in-person group sessions while a digital platform carries self-guided modules and therapist-supported activities into the hours between appointments, the very hours in which anxious children’s avoidance lives. Standardized psychoeducation moves online, freeing live sessions for the interactive and exposure-based work that depends on human connection. Reviews of digital mental health tools for young people report promising but uneven evidence, and researchers repeatedly caution that technology should augment rather than replace the therapeutic relationship. The Portuguese team spent years de-risking the model, publishing acceptability studies showing that parents viewed blended interventions for children’s emotional disorders positively and that psychologists expressed willingness to adopt them before the trial launched. The urgency is practical as much as scientific: implementation research identifies workforce shortages, long waiting lists, and difficulties maintaining treatment fidelity as the central barriers to evidence-based child mental health care, and blended designs are increasingly proposed as a structural answer to all three.

The trial’s statistical machinery was unusually ambitious for a pilot. Children aged 6 to 13 with a primary anxiety disorder — diagnoses established with the child and parent versions of the Anxiety Disorders Interview Schedule for DSM-IV, the field’s diagnostic benchmark — were randomly assigned to the blended program or to Coping Cat. The outcome battery combined clinician-rated severity and improvement on the Clinical Global Impression scales with child- and parent-reported anxiety and depressive symptoms on the Revised Children’s Anxiety and Depression Scale, and with the Child Anxiety Life Interference Scale, which captures how much fear and worry disrupt school, friendships, and family functioning. The team analyzed change over time using linear mixed-effects models, a framework well suited to longitudinal clinical trials because it accommodates repeated measurements and missing observations without discarding participants. Crucially, following the international CONSORT extension for non-inferiority and equivalence trials, the researchers pre-specified the margins within which the two programs would be considered statistically indistinguishable — a far more demanding standard than simply failing to find a significant difference. The trial was registered retrospectively on the Open Science Framework on 18 November 2025.

The results describe two therapies climbing in near parallel. Both interventions produced significant improvements over time across most outcomes, and remission and treatment response rates were comparable between groups. On the clinician-rated anchors — severity of the primary anxiety disorder and global improvement — the two programs did not differ significantly. The most striking signals favored the blended intervention: significant group-by-time interaction effects emerged for child-reported generalized anxiety, total anxiety, and overall symptom scores, indicating that children in the blended arm reported steeper symptom declines than their peers in Coping Cat. The single advantage for the established program was parent-reported family interference, which was significantly lower at post-treatment among children receiving Coping Cat. Depressive symptoms also eased in both conditions, a pattern consistent with the transdiagnostic claim that treating shared emotional mechanisms lifts distress across diagnostic boundaries. Taken together, between-group differences were limited, and the end-of-treatment picture was one of two working therapies built on different architectures.

The equivalence findings demand a careful read, and the authors supply one. In equivalence testing, the absence of a significant difference does not demonstrate sameness; investigators must show that any difference falls within a pre-defined margin judged clinically acceptable. On some primary outcomes the trial met those pre-specified criteria; on others it did not, yielding what the team describes as mixed results that should be interpreted cautiously given the pilot nature of the trial. With 77 participants, the study was not powered to settle the question definitively. “Larger, adequately powered randomized controlled trials are needed to determine whether the interventions achieve clinically equivalent outcomes,” the researchers conclude. That discipline is standard in early-phase clinical science, and it matters: pre-registered margins guard against reframing a null superiority result as equivalence after the fact, and a pilot equivalence trial is designed to estimate parameters and refine procedures, not to issue verdicts about routine care. The justified conclusion is that the blended format has earned the larger trials that must now follow.

The divergences among informants are scientifically informative in their own right. Longstanding research shows that children, parents, and clinicians often disagree when rating the same child’s symptoms, because each observer sees a different slice of the child’s life. That dynamic surfaced here: children receiving the blended program reported steeper relief from generalized anxiety, total anxiety, and overall symptoms, while parents of children in Coping Cat reported less anxiety-related disruption to family life, and clinicians applying standardized ratings saw no significant separation between the arms. With a sample of 77, small differences can also arise by chance, and none of these signals should be treated as decisive. What the overall pattern does establish is feasibility and preliminary efficacy: every measurement perspective recorded meaningful improvement, and nearly every head-to-head comparison returned a null result. For a novel delivery model, that consistency across informants is the strongest signal a pilot trial can send.

If fully powered trials confirm these findings, the implications extend well beyond Portugal. A transdiagnostic group protocol with a digital backbone attacks three bottlenecks at once: the shortage of therapists trained in disorder-specific manuals, the inefficiency of running separate programs for anxiety and depression, and the fragility of between-session practice when treatment exists only inside a clinic. The study was funded by the Portuguese Foundation for Science and Technology and conducted by teams at the University of Coimbra and the University of Lisbon, with Dave Skvarc of Deakin University in Australia and Jill Ehrenreich-May of the University of Miami, co-developer of the Unified Protocols for children and adolescents, among the co-authors. The authors remain measured, noting that equivalence findings were mixed and that Coping Cat’s three-decade evidence base remains the standard. But the direction of travel is unmistakable. The next steps are larger trials, longer follow-up, and studies identifying which children thrive with digital augmentation and which still need the full weight of in-person care. If the results hold, anxious children on those long waiting lists may one day find help arriving partly through a screen — without losing the healing power of a room full of children learning, together, to face their fears.